Table 1 Demographics of the entire cohort
Variable | Levels | Values |
|---|---|---|
Age | Median [IQR] | 66.4 [13.3] |
Sex | Male | 139 (55.2%) |
Female | 113 (44.8%) | |
Adjuvant Chemotherapy | Given | 74 (29.4%) |
Observation | 178 (70.6%) | |
Histologic Grade | 1 | 2 (0.8%) |
2 | 186 (73.8%) | |
3 | 64 (25.4%) | |
Lymphovascular Invasion | Present | 144 (57.1%) |
Absent | 108 (42.9%) | |
Perineurial Invasion | Present | 232 (92.1%) |
Absent | 20 (7.9%) | |
pT Stage | 1 | 2 (0.8%) |
2 | 11 (4.4%) | |
3 | 238 (94.4%) | |
4 | 1 (0.4%) | |
pN Stage | 0 | 64 (25.4%) |
1 | 168 (74.6%) | |
Resection Status | R0 | 190 (75.4%) |
R1 | 62 (24.6%) | |
CD3 Epithelial | Median [IQR] | 0 [0] |
CD3 Stromal | Median [IQR] | 50 [52] |
CD8 Epithelial | Median [IQR] | 0 [0] |
CD8 Stromal | Median [IQR] | 11 [36] |
MMR Status | Proficient | 211 (84.1%%) |
Deficient | 40 (15.9%) | |
Follow-up Time (Years) | Median [IQR] | 1.33 [1.59] |
Events | Disease Specific Deaths | 200 (79.4%) |
Censorings | 52 (20.6%) |